In recent years, the European Union has undertaken significant reforms to enhance the safety and quality of substances of human origin (SoHO), which encompass blood, tissues, cells, and other human-derived materials used in medical treatments. These reforms aim to modernize the regulatory framework, ensuring it… Read More »Council adopts new rules on substances of human origin
INTRO: An EuMAR project stakeholder meeting was held on the 5th of December 2023 presenting the status and receiving feedback from participants being National Competent Authorities (NCA), patient interest organisations, fertility professionals and other parties of relevance to the fertility sector and its future developments.… Read More »EuMAR project – stakeholder meeting sum-up
Together with the European Parliamentary Forum for Sexual & Reproductive Rights (EPF), ESHRE’s patient partner organisation Fertility Europe has recently launched a a White Paper on the Imperative of Equal Access to Fertility Treatments across Europe, including the following 12 key recommendations to policy makers:… Read More »Equal Access to Fertility Treatments across Europe
Research with an article published at Human Reproduction by an ESHRE working group outlines a set of add-on tests and treatments, describes the biological rationale and where available the evidence of their efficacy and safety. The ESHRE appointed working group further makes recommendations for clinical… Read More »Fertility treatment add-ons – research & recommendations
PGT-A (previously known as preimplantation genetic screening or PGS) involves checking a few cells of the embryos for potential abnormalities in the number of chromosomes. Embryos with an abnormal number of chromosomes in all or in the majority of their cells (known as aneuploid embryos)… Read More »Non-invasive preimplantation genetic testing (niPGT) – success rates?
A survey has been launched to help women in England shape reproductive health policy by sharing their experiences of a range of issues. The government launched the survey to get women’s views on issues including periods, contraception, fertility, pregnancy and the menopause, as part of… Read More »Landmark survey seeks women’s views on reproductive health in England
What is the patient journey? Firstly, let’s consider the meaning of ‘the patient journey’. It is the entire sequence of events that begins when the patient first becomes aware of your clinic. That could be browsing your clinic website, interacting with your social media or… Read More »The patient journey: why it is vital to fertility clinic success?
Max. 5 years storage of human eggs The Danish government has announced on Monday that it will remove the current five-year limit on how long healthy women can store eggs in the freezer for potential future use at fertility treatments. Social freezing – the facts… Read More »Danish Government to remove restriction on max. 5 years storage of human eggs
The EU’s tissue and cell directives will shortly be superseded by a new single legislation; ESHRE outlines the ‘key considerations’The European Commission has published its proposed legislation for substances of human origin (SoHO) and is presently in a consultation phase. Let us hope the new… Read More »New EU legislation on ART pending
New legislation in Greece creates a very progressive legal framework for the development of MAR/ART in the country improving people’s access to have treatment and help in having children. The status and demographic trends in Greece The demographic indicators of Greece reveal a continuous decrease… Read More »New progressive MAR/ART legislation in Greece